Onderzoeker
Johan Van Cleemput
- Disciplines:Cardiale en vasculaire geneeskunde
Affiliaties
- Cardiologie (Afdeling)
Lid
Vanaf1 okt 2000 → Heden
Projecten
1 - 2 of 2
- Geïntegreerde PK/PM Model-gebaseerde Medicatie Dosering Assistentie App(licatie) in het Klinisch Werk Station (KWS). Validatie Studies van Tacrolimus in Orgaan Transplantatie.Vanaf1 jan 2021 → 31 dec 2023Financiering: IOF - technologie validatie in labo
- Evaluatie van nieuwe predictoren van transplantvasculopathie in harttransplantrecipiënten.Vanaf1 jan 2010 → 31 dec 2013Financiering: FWO Onderzoeksproject
Publicaties
81 - 90 van 107
- LONG-TERM OUTCOME AFTER MEDICAL AND INVASIVE TREATMENT IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY(2014)
Auteurs: Pieter A Vriesendorp, Max Liebregts, Robbert Steggerda, Arend Schinkel, Rik Willems, Folkert Ten Cate, Johan Van Cleemput, Jurrien Ten Berg, Michelle Michels
Pagina's: A763 - A763 - Independent validation of the novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)(2014)
Auteurs: PA Vriesendorp, AFL Schinkel, M Liebregts, R Willems, FJ Ten Cate, Johan Van Cleemput, M Michels
Pagina's: 210 - 210 - AMOUNT OF ALCOHOL HAS NO LONG-TERM EFFECT ON MORTALITY AFTER ALCOHOL SEPTAL ABLATION(2014)
Auteurs: Pieter A Vriesendorp, Max Liebregts, Robbert Steggerda, Arend Schinkel, Rik Willems, Folkert Ten Cate, Johan Van Cleemput, Jurrien Ten Berg, Michelle Michels
Pagina's: A878 - A878 - Right ventricular work increase during strenuous exercise is greater than for the left ventricle: results from a real-time exercise cardiac magnetic resonance study(2013)
Auteurs: Andre La Gerche, Guido Claessen, Alexander Van De Bruane, Jan Bogaert, Johan Van Cleemput, Piet Claus, Hein Heidbuchel
Pagina's: 21 - 22 - Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications(2013)
Auteurs: Johan Van Cleemput, Rik Willems, Thomy de Ravel de l'Argentière
Pagina's: 496 - 502 - Peripartum cardiomyopathy(2013)
Auteurs: Johan Van Cleemput
Pagina's: 697 - 705 - Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection(2013)
Auteurs: Davy Vanhoutte, Lucas Van Aelst, Johan Van Cleemput, Frans Van de Werf, Peter Carmeliet, Johan Vanhaecke, Anna-Pia Papageorgiou, Stephane Heymans
Pagina's: 1930 - 1941 - Response to letter regarding article, "Cardiac magnetic resonance imaging: a new gold standard for ventricular volume quantification during high-intensity exercise"(2013)
Auteurs: Andre La Gerche, Guido Claessen, Alexander Van De Bruaene, Johan Van Cleemput, Marc Gewillig, Jan Bogaert, Steven Dymarkowski, Piet Claus
Pagina's: E20 - E20 - The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder(2013)
Auteurs: Daan Dierickx, Thomas Tousseyn, Xavier Sagaert, An Herreman, Dirk Kuypers, Johan Van Cleemput, Frederik Nevens, Lieven Dupont, Anne Uyttebroeck, Jacques Pirenne, et al.
Pagina's: 771 - 775 - Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump(2013)
Auteurs: Steven Jacobs, Filip Rega, Kathelijne Peerlinck, Marc Jacquemin, Johan Vanhaecke, Johan Van Cleemput, Bart Meyns
Pagina's: 539 - 45